Effects of Functional Electrical Stimulation Cycling Versus Cycling Only on Walking and Quality of Life in MS
NCT ID: NCT02606604
Last Updated: 2019-09-30
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2015-11-30
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Innovative Approaches to Enhance Balance and Neuroplasticity in Multiple Sclerosis
NCT07174973
Non-invasive Brain Stimulation Paired With FES Cycling Post SCI
NCT05975606
Neuromodulation in MS Using Translingual Stimulation
NCT05275049
Functional Electrical Stimulation for Individuals With Secondary Progressive Multiple Sclerosis
NCT01647321
The Effects of FES in a Variety of Walking Conditions in People With MS
NCT03410498
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FES Cycling
The intervention consists of electrical stimulation to five lower extremity muscle groups (quadricep, hamstring, anterior tibialis, gluteal, and gastrocnemius muscle groups) while cycling for 45 minutes, 3 times per week for 8 weeks. Outcome measures will be collected at baseline, 4 weeks, 8 weeks and 4 weeks after training is completed).
RT 300: Lower Extremity Cycling
Individuals will be randomly assigned to either the FES cycling or cycling only group and will perform lower extremity cycling. Individuals will participate in an interval training cycling program 3 times per week for 8 weeks.
Cycling Only
The intervention consists of lower extremity cycling for 45 minutes, 3 times per week for 8 weeks. Electrical stimulation will not be applied to any muscles. Outcome measures will be collected at baseline, 4 weeks, 8 weeks and 4 weeks after training is completed.
RT 300: Lower Extremity Cycling
Individuals will be randomly assigned to either the FES cycling or cycling only group and will perform lower extremity cycling. Individuals will participate in an interval training cycling program 3 times per week for 8 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RT 300: Lower Extremity Cycling
Individuals will be randomly assigned to either the FES cycling or cycling only group and will perform lower extremity cycling. Individuals will participate in an interval training cycling program 3 times per week for 8 weeks.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient-determined Disease Steps score between 3.0 and 6.0 inclusive
* Ability to attend training sessions 3 times per week for an 8-10 week period
* Passing a submaximal exercise test
* Adequate hip range of motion (at least 110 degrees)
* Adequate knee range of motion (10-90 degrees)
Exclusion Criteria
* History or presence of other neurological pathologies that interfere with movement
* Received physical therapy within the last 4 weeks prior to the study
* History of an acute exacerbation of their MS symptoms within 4 weeks prior to the study
* Immunosuppressive or steroid therapy within the past 4 weeks
* Significant spasticity in the legs that interferes with the cycling motion
* History of congestive heart failure
* Coronary Artery Disease
* Uncontrolled Hypertension
* History of epilepsy or seizures
* Cardiac demand pacemaker or implanted defibrillator
* Unhealed fractures in the legs
* Pressure sores or open wounds on the legs
* Pregnant or trying to conceive
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stony Brook University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lori Hochman
Clinical Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lori I Hochman, PT, PhD
Role: PRINCIPAL_INVESTIGATOR
Stony Brook University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Stony Brook Univeristy
Stony Brook, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
534378-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.